Hematologic Disorders News Today

Data suggest that risk increases even with low radiation doses.

Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Rare Disease Clinical Trials Market Size, Share & Trends Analysis Report By Therapeutic Area...

Avapritinib (AYVAKIT) is now approved to treat adults with indolent systemic mastocytosis.

As per the report by Visiongain, the Rare Diseases Market was valued at US$188.58 billion in 2022 and is projected to grow at a CAGR of 12.27% during the...

Women with sickle cell disease have high-risk pregnancies with significant potential for health crises and death; physicians are concerned that tighter restrictions on abortions may compromise their care.

More than 900 medical facilities have been destroyed or damaged, says Ruslan Zelinskyi, MS, from the Spizhenko Clinic in Ukraine.

A liquid biopsy test used for molecular profiling in patients with solid tumors also identified patients who were at risk for clonal hematopoiesis, which may develop into myeloid blood cancer.

Single-dose gene therapy, betibeglogene autotemcel, may represent a cure for most with beta-thalassemia, but it costs a record-high $2.8 million. Details on how coverage will work remain murky

"If patients know they have the diagnosis, and they do the right things and avoid alcohol and risky drugs, most people will have few acute attacks."

Moral distress from being unable to provide appropriate care or being forced into making questionable decisions is common in oncology, and it needs to be addressed.